San Francisco – Aug. 19, 2021 – Real Chemistry’s IPM.ai, the leader in uncovering undiagnosed and misdiagnosed patients via machine learning, and Datavant, the leader in helping healthcare and...

Allison Rhee of MM&M reports on IPM.ai's answer to patient finding for rare and specialty diseases through advanced AI/ML. Read the full text below:

The rare disease patient journey can be arduous. Many patients experience multiple misdiagnoses or go undiagnosed before finally figuring out their true health issue and receiving treatment. For...

August 9, 2021

IPM.ai's Clinical Trial Recruitment Solution Featured in MM&M

0

Allison Rhee of MM&M reports on IPM.ai's answer to patient finding for rare and specialty diseases through advanced AI/ML. Read the full text below: